Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert S Wiesenthal is Chief Executive Officer at Strata Critical Medical. OQRO lists 1 transaction filed with the SEC under this name, the latest on Nov 15, 2024, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
1
Companies involved
1
Nov 14, 2024Sold~$6.76Mdisclosed Nov 15
DetailsOfficial recordRobert S Wiesenthal has no open-market purchase on record since 2022. Sales in 3 of the 5 years since 2022.
Robert S Wiesenthal reported 0 open-market purchases and 18 sales since 2022; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $7.21M4×4 trades |
| 2023 | — | $1.69M13×13 trades |
| 2022 | — | $38K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Robert S Wiesenthal reported 0 open-market purchases and 18 sales here, 2022 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
As of the latest filing on , Robert S Wiesenthal reported holding 4,812,892 shares of Strata Critical Medical (SRTA), worth about $26.5M at the last close of $6 (Nov 13, 2026).
Strata Critical Medical's proxy statement reports total compensation of $5.05M for Robert S Wiesenthal for fiscal year 2025, after $9.56M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 14, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Strata Critical Medical SRTA | 4,812,892 | 4.81M direct | $6 | $26.5M | Nov 14, 2024 |
Is this Robert S Wiesenthal’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 14, 2024, Robert S Wiesenthal reported holding 4,812,892 shares of Strata Critical Medical (SRTA). At the last close of $6 on Nov 13, 2026, that is about $26.5M. This is the stake disclosed in filings, not a net worth.
Strata Critical Medical's proxy statement reports total compensation of $5.05M for Robert S Wiesenthal for fiscal year 2025, after $9.56M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Robert S Wiesenthal has no open-market purchase on record since 2022. Sales in 3 of the 5 years since 2022.
In SEC filings since 2022: no open-market purchase is on record; the latest open-market sale is from 2024.
Strata Critical Medical (SRTA), from 2022 to 2024: 0 purchases and 18 sales.
